This observational analysis reveals higher viral-bacterial codetection rates in SARS-CoV-2 patients, suggesting implications for pneumonia treatment.
Pneumonia is a leading cause of death worldwide, especially among children and the elderly, mainly due to viral and bacterial infections. During the COVID-19 pandemic, cases rose as SARS-CoV-2 also causes pneumonia. This study investigates viral and bacterial detection among SARS-CoV-2 suspected patients with pneumonia admitted to the health care facilities in Jakarta, Indonesia. Of the 245 pneumonia cases, 80 (33%) were confirmed positive for SARS-CoV-2. Among other viruses, paramyxovirus and herpesvirus were the predominant viruses identified (each 7%) followed by influenza virus (5%) and enterovirus (2%). Bacterial screening of nasopharyngeal swab specimens detected 21 (9%) and 14 (6%) positive for Haemophilus influenzae and Streptococcus pneumoniae respectively. Overall, the higher rate of viral-bacterial codetection was observed in the SARS-CoV-2 positive cases than in the negative cases. We found that viral-bacterial codetection without any significant association with clinical manifestation, patient outcome or severity.Pneumonia is a leading cause of death worldwide, especially among children and the elderly, mainly due to viral and bacterial infections. During the COVID-19 pandemic, cases rose as SARS-CoV-2 also causes pneumonia. This study investigates viral and bacterial detection among SARS-CoV-2 suspected patients with pneumonia admitted to the health care facilities in Jakarta, Indonesia. Of the 245 pneumonia cases, 80 (33%) were confirmed positive for SARS-CoV-2. Among other viruses, paramyxovirus and herpesvirus were the predominant viruses identified (each 7%) followed by influenza virus (5%) and enterovirus (2%). Bacterial screening of nasopharyngeal swab specimens detected 21 (9%) and 14 (6%) positive for Haemophilus influenzae and Streptococcus pneumoniae respectively. Overall, the higher rate of viral-bacterial codetection was observed in the SARS-CoV-2 positive cases than in the negative cases. We found that viral-bacterial codetection without any significant association with clinical manifestation, patient outcome or severity.
No takes yet. Share an insight, caveat, or question.
Wiyatno et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: